Breakthrough study captures polygenic risk scores for CAD in South Asia

The US biotechnology company Verve Therapeutics presented a new preclinical proof-of-concept data on successful use of base editing to turn off a gene in the liver and thereby lower blood levels of either LDL cholesterol or triglyceride-rich lipoproteins, two factors leading to coronary atherosclerosis.

Oliceridine (Olinvyk), a first-in-class intravenous (IV) analgesic has recently received the US FDA approval for management of moderate to severe acute pain in adults.

Russia plans to register the world’s first vaccine against SARS CoV-2 infection on August 12, according to agency reports quoting Deputy Health Minister Oleg Gridnev.

India registered 53,601 new COVID positive cases on Monday. The country, which has been registering more number of new cases than the two most affected countries such as the US and Brazil in the last one week, has so far reported 2,268,675 positive cases in all.

An adenoviral serotype 5 (Ad5) vectored COVID-19 vaccine candidate developed by the Chinese researchers is set to enter phase 3 clinical trial in Saudi Aradia, announced CanSino Biologics.

Researchers at the University of Maryland School of Medicine have developed a microfluidic device that could help preserve and detect the presence of thin membrane protrusions called “microtentacles” on breast cancer cells which can help image non-adherent cells to detect whether a tumour is likely to spread.